AI Science Tracker
EN

Gut Clostridium aminophilum as a protective microbe in never-smoker lung cancer: insights from metagenomics and machine learning

Department of Thoracic Surgery, Shaoxing people's hospital, Shaoxing, Zhejiang, China; Wenzhou Medical University, Wenzhou, Zhejiang, China; Department of Intensive Care Unit, Guangdong Provincial People's Hospital, Zhuhai Hospital (Jinwan Central Hospital of Zhuhai), Zhuhai, Guangdong, China; Shaoxing University, Shaoxing, Zhejiang, China · 26 Oct 2026 · biology

Discovery

Gut Clostridium aminophilum as a protective microbe in never-smoker lung cancer: insights from metagenomics and machine learning

Source check: Source checked. Not independent scientific confirmation.

Finding: The model prioritized Clostridium aminophilum as depleted in the LCINS cohort and as a candidate protective microbe; the paper reports supporting cell and mouse tumor-suppression experiments. Held-out test AUC 0.886 (mean 0.855); reduced abundance replicated in an independent NSCLC cohort (29 controls/27 cases), with in-vitro cell and in-vivo xenograft follow-up. The small cohort and non-LCINS replication limit clinical specificity; causal/organism-specific effects remain unresolved.

Technology: glmBoost feature selection plus ridge classification, interpreted with SHAP to prioritize a candidate gut microbe

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
glmBoost feature selection plus ridge classification, interpreted with SHAP to prioritize a candidate gut microbe
Test and result
The model prioritized Clostridium aminophilum as depleted in the LCINS cohort and as a candidate protective microbe; the paper reports supporting cell and mouse tumor-suppression experiments.
Limitation / still unknown
Held-out test AUC 0.886 (mean 0.855); reduced abundance replicated in an independent NSCLC cohort (29 controls/27 cases), with in-vitro cell and in-vivo xenograft follow-up. The small cohort and non-LCINS replication limit clinical specificity; causal/organism-specific effects remain unresolved.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://journals.asm.org/doi/10.1128/spectrum.00994-26

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse biology discoveries.